🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Eloxx Pharmaceuticals, Inc. (ELOX)
NASDAQ: ELOX · Real-Time Price · USD
10.65
+0.24 (2.31%)
At close: Nov 19, 2026, 4:00 PM EST
10.66
+0.01 (0.09%)
After-hours: Nov 19, 2026, 4:10 PM EST

Eloxx Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-15.84-6-3.14-17.05-36.07-66.73
Depreciation & Amortization
--0.160.810.70.96
Other Amortization
0.030.250.470.260.540.42
Loss (Gain) From Sale of Assets
-0-0-0.04-0.29-0.08
Asset Writedown & Restructuring Costs
----0.0422.67
Stock-Based Compensation
0.520.240.541.973.029.17
Other Operating Activities
-1.29-1.33-0.35-0.880.05-0.54
Change in Accounts Receivable
-2.72-2.72---
Change in Accounts Payable
-0.97-2.63-0.352.681.64-0.32
Change in Other Net Operating Assets
-1.030.440.72-1.84-1.76-0.72
Operating Cash Flow
-18.58-6.33-4.72-14.34-31.85-35
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-----0.07-0.09
Sale of Property, Plant & Equipment
000.040.31--
Cash Acquisitions
-----2.15
Investing Cash Flow
000.040.31-0.072.06

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
--0.380.43--
Long-Term Debt Issued
-2.873.67--11.87
Total Debt Issued
-2.874.050.43-11.87
Short-Term Debt Repaid
--0.3----
Long-Term Debt Repaid
--1.26-0.61-9.4--11.38
Total Debt Repaid
-0.3-1.56-0.61-9.4--11.38
Net Debt Issued (Repaid)
-0.31.313.44-8.97-0.49
Issuance of Common Stock
58.92--4.89-47.74
Repurchase of Common Stock
------0.36
Other Financing Activities
12.029.69--8.812.92
Financing Cash Flow
70.64113.44-4.088.8150.79

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
52.054.68-1.24-18.11-23.117.84

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-18.58-6.33-4.72-14.34-31.91-35.09
Free Cash Flow Growth
------
Free Cash Flow Margin
---74.15%---
Free Cash Flow Per Share
-2.88-5.64-13.80-61.37-162.04-220.68
Levered Free Cash Flow
--4.9-3.47-6.47-17.96-14.61
Unlevered Free Cash Flow
--4.49-3.22-6.01-17.28-14.25

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.030.030.140.991.370.73
Change in Working Capital
-20.52-2.360.84-0.12-1.04